Clinical Trials in Florida
View paid research studies that are recruiting in Florida. Filter by distance, duration, and inclusion criteria to find clinical trials that pay well for your time.
Reviewed by Michael Gill, B. Sc.
Cohort 1: SDX/d-MPH In 4-5 Year Oldfor Attention Deficit Hyperactivity Disorder (ADHD)
4 - 12
Little Rock, AR
This trial will study the efficacy and safety of a medicine (Azstarys®) for treating ADHD in children 4-12 years old. 130 & 100 children from 20 sites will be enrolled and randomized.
Preferred Research Partners (PRP) (+21 Sites)Ann Childress, MDCorium, Inc.
18 - 65
This trial is testing a new drug to see if it is effective and safe. The trial is comparing the new drug to a placebo, and is double-blind, meaning neither the participants nor the researchers will know who is receiving which until the trial is over.
AMR Mobile (+14 Sites)Ology Bioservices
Crossover ProVee Urethral Expander Systemfor Benign Prostatic Hyperplasia
Las Vegas, NV
This trial is studying a device to treat urinary obstruction caused by an enlarged prostate.
Sheldon Freedman MD (+7 Sites)ProVerum Medical
Nipocalimabfor Myasthenia Gravis
Paradise Valley, AZ
This trial will test if nipocalimab is more effective and safe than placebo for treating generalized myasthenia gravis.
Neuromuscular Research Center and Clinic (+26 Sites)Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC
18 - 70
Middleburg Heights, OH
This trial will test a new Lupus medication to see if it is effective, safe, and well tolerated.
Local Institution (+24 Sites)Bristol-Myers SquibbBristol-Myers Squibb
Abemaciclibfor Breast Cancer
This trial is testing abemaciclib as a treatment for early breast cancer in people who are also taking hormone therapy. It will last up to 10 years.
University of Alabama at Birmingham (+99 Sites)Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company
San Francisco, CA
This trial is testing a new cell therapy that consists of T cells that have been genetically engineered to express a single-domain antibody that recognizes human Mesothelin. The T cells are fused to the CD3-epsilon subunit, which is incorporated into the endogenous T cell receptor (TCR) complex. The aim of the trial is to establish the recommended Phase 2 dose and to evaluate the efficacy of the therapy in patients with advanced mesothelin-expressing cancers.
Phase 1 & 2
University of California, San Francisco (+10 Sites)ClinicalTCR2 Therapeutics
Abrocitinib 200 Mgfor Atopic Dermatitis
This trial is studying whether a new drug, abrocitinib, is effective and safe for treating atopic dermatitis in patients aged 12 years and older. The trial consists of an initial treatment period of 92 weeks, followed by a secondary treatment period of variable length during which subjects will receive treatment with open-label abrocitinib until availability of commercial product in their country, or until the sponsor terminates the study in that country. There is also a sub-study evaluating whether abrocitinib has any potential effects on adolescent bone with regard to abnormal bone findings in knee MRI.
ForCare Clinical Research (+12 Sites)Pfizer CT.gov Call CenterPfizer
12 - 21
This trial is testing how well olaparib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with defects in DNA damage repair genes.
Children's Hospital of Alabama (+98 Sites)Julia Glade-Bender
Micronized DHACM 40 Mgfor Osteoarthritis
21 - 80
La Mesa, CA
This trial tests two doses of a new injection to treat knee osteoarthritis to see if it's safe and effective compared to a placebo.
Horizon Clinical Research (+24 Sites)MiMedx Group, Inc.
10 Florida Clinical Trials Near Me